ARTICLE | Company News
Macugen gets CHMP positive opinion
September 16, 2005 11:54 PM UTC
The EMEA's CHMP issued a positive opinion for Macugen pegaptanib from Eyetech (EYET) and Pfizer (PFE) to treat neovascular (wet) age-related macular degeneration (AMD). A decision is expected by year ...